In a 12-week study, participants receiving 1 mg daily lost an average of 2.6 kg (approximately 5.7 pounds) compared to 0.8 kg in the placebo group
Great product, arrived in a timely manner
It is not a standalone weight loss treatment and is not FDA-approved to diagnose, treat, cure, or prevent any disease
In the aforementioned study from our group, adult mice with partial IGF-1 also displayed decreased expression of genes involved in lipid metabolism (ATP-citrate lyase, acetyl-CoA acyltransferase 1B, acetyl-CoA acetyltransferase 1) and cholesterol synthesis and transport (Both HMG-CoA reductase and synthase, LDL-related protein 1, proprotein convertase subtilisin/Kesin type 9), resulting in dyslipidaemia
Hydroxocobalamin sometimes provides longer tissue retention
There are specific guidelines to qualify for these injections at your NHS practice, so we would advise that you speak with your G.P directly for more information